Fisayo A Olotu Selected Research

CRTH2 antagonist CT-133

3/2020

Lipid-Embedded Molecular Dynamics Simulation Model for Exploring the Reverse Prostaglandin D2 Agonism of CT-133 towards CRTH2 in the Treatment of Type-2 Inflammation Dependent Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fisayo A Olotu Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 03/2018
8	Alzheimer Disease (Alzheimer's Disease) 02/2021 - 01/2018
3	Carcinogenesis 01/2022 - 03/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 06/2019
2	Infections 02/2021 - 11/2020
2	COVID-19 01/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 04/2020 - 01/2019
2	Immune System Diseases (Immune Disorders) 06/2019 - 04/2018
1	Lung Neoplasms (Lung Cancer) 08/2021
1	Colonic Neoplasms (Colon Cancer) 07/2021
1	autosomal dominant Spastic paraplegia 6 03/2021
1	Parkinson Disease (Parkinson's Disease) 03/2021
1	Chagas Disease (American Trypanosomiasis) 02/2021
1	Cryptosporidiosis 01/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2020
1	Extensively Drug-Resistant Tuberculosis 04/2020
1	Acute Lung Injury 03/2020
1	Inflammation (Inflammations) 03/2020
1	Hypersensitivity (Allergy) 03/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Allergic Rhinitis 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Disease Progression 01/2019
1	Periodontal Diseases (Periodontal Disease) 11/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2018

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 03/2021 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2018
2	Poly (ADP-Ribose) Polymerase-1IBA 08/2021 - 01/2021
2	bedaquiline (R207910)IBA 04/2020 - 01/2019
2	J147IBA 01/2020 - 06/2019
2	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2020 - 06/2019
2	naringeninIBA 12/2018 - 01/2018
1	Deubiquitinating EnzymesIBA 01/2022
1	ChalconesIBA 10/2021
1	Monoamine Oxidase (MAO)IBA 10/2021
1	ChlorineIBA 08/2021
1	Retinoid X Receptors (Retinoid X Receptor)IBA 07/2021
1	BerberineIBA 07/2021
1	CarbonIBA 03/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2021
1	benzofuranIBA 03/2021
1	EnzymesIBA 02/2021
1	SirtuinsIBA 02/2021
1	GlucokinaseIBA 02/2021
1	HexokinaseIBA 02/2021
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Subunit VaccinesIBA 01/2021
1	castanospermineIBA 11/2020
1	karuquinone BIBA 11/2020
1	Protein Kinases (Protein Kinase)IBA 09/2020
1	Threonine (L-Threonine)FDA Link 09/2020
1	Serine (L-Serine)FDA Link 09/2020
1	Caspase 6IBA 09/2020
1	LigandsIBA 04/2020
1	2,4-diaminopyrimidineIBA 03/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 03/2020
1	LipidsIBA 03/2020
1	CRTH2 antagonist CT-133IBA 03/2020
1	SmokeIBA 03/2020
1	ramatrobanIBA 03/2020
1	Prostaglandin D2IBA 03/2020
1	Monoclonal AntibodiesIBA 01/2020
1	SARS-CoV-2 spike proteinIBA 01/2020
1	Y08197IBA 01/2020
1	KRN 7000 (KRN7000)IBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	ElementsIBA 01/2020
1	Galactosylceramides (Galactocerebrosides)IBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 12/2019
1	AntibodiesIBA 06/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CaspasesIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	CAY 10471IBA 01/2019
1	fevipiprantIBA 01/2019
1	TankyrasesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Semaphorin-3AIBA 12/2018
1	leukotoxinIBA 11/2018
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2018

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2019
2	Immunotherapy 01/2020 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Ligation 03/2020